Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New anticoagulants reported by Berlex

Jan. 2, 1998

No Comments

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

No Comments

Improved method for vWF purification developed by Bayer

Dec. 31, 1997

No Comments

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Dec. 29, 1997

No Comments

Tanabe Seiyaku claims new PAI-1 inhibitors

Dec. 24, 1997

No Comments

FDA issues health advisory for anticoagulants

Dec. 18, 1997

No Comments

Promising results reported from rhATIII trial

Dec. 18, 1997

No Comments

Boehringer Mannheim describes antiplatelet agents

Dec. 18, 1997

No Comments

Phase II trial of Vasoflux begins in acute MI

Dec. 17, 1997

No Comments

Cytoprotective effects of TTC-909 demonstrated in SHR-SP

Dec. 15, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

New anticoagulants reported by Berlex

Banyu searches for potent, orally bioavailable FXa inhibitors

Improved method for vWF purification developed by Bayer

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Tanabe Seiyaku claims new PAI-1 inhibitors

FDA issues health advisory for anticoagulants

Promising results reported from rhATIII trial

Boehringer Mannheim describes antiplatelet agents

Phase II trial of Vasoflux begins in acute MI

Cytoprotective effects of TTC-909 demonstrated in SHR-SP

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase III AMD miss leaves BLA Outlook same with bevacizumab

Hematologic RSS

Hematologic
RSS